menu
    • menu

    Company profile for CervoMed

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CervoMed is a clinical-stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as EIP Pharma Inc. EIP Pharma Inc is now a wholly-owned subsidiary of CervoMed. The company's lead product candidate, neflamapimod, is currently in clinical development as a disease-modi...
    CervoMed is a clinical-stage company dedicated to the development and commercialization of drug treatments for neurodegenerative diseases with a focus on the early stages of the neurodegenerative process. Until August 2023, CervoMed was known as EIP Pharma Inc. EIP Pharma Inc is now a wholly-owned subsidiary of CervoMed. The company's lead product candidate, neflamapimod, is currently in clinical development as a disease-modifying treatment for neurodegenerative diseases, such as dementia with Lewy Bodies and early Alzheimer’s disease. In addition, pre-clinical data supports the potential role of neflamapimod in recovery after stroke.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CervoMedUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Park Plaza, Suite 424 Boston, MA 02116
    Telephone
    Telephone
    +1 6177444400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cervomed.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/cervomed/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Cervo_Med

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cervomed Reveals Neflamapimod Slows Dementia Progression At CTAD
    Cervomed Reveals Neflamapimod Slows Dementia Progression At CTAD

    04 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/04/3200383/0/en/CervoMed-Announces-Late-Breaking-Data-at-the-18th-CTAD-Conference-Demonstrating-Neflamapimod-Significantly-Slows-Clinical-Progression-in-Dementia-with-Lewy-Bodies.html

    GLOBENEWSWIRE
    04 Dec 2025
    Share Share
    CervoMed's New Data on Neflamapimod in DLB at CTAD 2024
    CervoMed's New Data on Neflamapimod in DLB at CTAD 2024

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193345/0/en/CervoMed-to-Share-New-Data-on-Neflamapimod-as-a-Treatment-for-Dementia-with-Lewy-Bodies-at-the-18th-Clinical-Trials-on-Alzheimer-s-Disease-CTAD-Conference.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Cervomed Reports Q3 2025 Financials & Corporate Updates
    Cervomed Reports Q3 2025 Financials & Corporate Updates

    10 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/10/3184371/0/en/CervoMed-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates.html

    GLOBENEWSWIRE
    10 Nov 2025
    Share Share
    Cervomed Appoints David Quigley To Strengthen Board
    Cervomed Appoints David Quigley To Strengthen Board

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175343/0/en/CervoMed-Strengthens-Board-with-Appointment-of-Life-Sciences-Business-Strategy-Leader-David-Quigley.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Cervomed To Present At The Emerging Growth Conference
    Cervomed To Present At The Emerging Growth Conference

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169277/0/en/CervoMed-to-Present-at-the-Emerging-Growth-Conference.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share
    CervoMed Reports Ph2b Data On Neflamapimod In Lewy Body Dementia
    CervoMed Reports Ph2b Data On Neflamapimod In Lewy Body Dementia

    08 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/08/3163184/0/en/CervoMed-Announces-New-Data-from-Phase-2b-Trial-Demonstrating-Neflamapimod-s-Potential-as-a-Treatment-for-Dementia-with-Lewy-Bodies.html

    GLOBENEWSWIRE
    08 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search